Leaderboard
Anzeige
medline.ch
En
|
De
Impressum
No articles selected!
View Cart
You are here:
Urology-Nephrology
»
Neoplasia/BPH
10. April 2026
Search
medline.ch
Neoplasia/BPH
Advanced search
Dermatology
Endocrinology
Nutrition
Gastroenterology
Gynecology
Haematology
Infectious diseases
Cardiovascular Diseases
Musculoskeletal Diseases
Neurology
Oncology
ORL
Pediatrics
Psychiatry
Respiratory Tract
Sports
Urology-Nephrology
Inflammation-Infection
Nephrolithiasis
Renal Failure
Sexuality
Neoplasia/BPH
Others
Rect Top
Anzeige
Zoom:
Page 1 of 9346
Articles 1 - 20 / 186904
Expression of lncRNA-ATB and miR-200c in patients with bladder cancer: a pilot study.
Lab Med
Kaytaz M, Degirmenci ME, Kucukgergin C, Aydin AF, Sanli O, Erdem S, Ozcan F, Ozluk Y, Dogru Abbasoglu S.
PMID: 41955422 [PubMed - indexed for MEDLINE]
Renal Oncocytic Neoplasms: Review of Classification Updates, Imaging, and Management.
Radiographics
Akobeng MA, Bhayana R, Di Loreto M, Taffel M, Woo S, Tirumani SH, Shanbhogue K, Prendeville S, Elsayes K, Schieda N, Silverman SG, Krishna S.
PMID: 41955128 [PubMed - indexed for MEDLINE]
Screening policy changes and prostate cancer epidemiology: 20-year trends in diagnosis, treatment, incidence, and mortality.
World J Urol
Jin S, Xia K, Wang J, Zhang H, Ye YN.
PMID: 41954768 [PubMed - indexed for MEDLINE]
Renal medullary carcinoma: a systematic review of clinical and radiological findings.
Int Urol Nephrol
Weston W, Sit C, Dafydd DA, Kelly-Morland C, Sohaib A, Adamane S, Manickavasagar T, Pickering L, Nicol D, Withey SJ.
PMID: 41954690 [PubMed - as supplied by publisher]
The Proposed Introduction of a Prostate Cancer Screening Program in Germany: Procedure, Necessary Studies before Implementation, Benefits, and Risks.
Dtsch Arztebl Int
Albers P, Carlsson S, Krilaviciute A, Seibold P, Becker N.
PMID: 41954430 [PubMed - as supplied by publisher]
Safety, Feasibility and Prognostic Analysis of Surgical Treatment for High-Complexity Renal Tumours (RENAL Score ≥ 10): A Summary of Experience With Robotic Technology Applications.
Int J Med Robot
Xu L, Wang J, Shi Y, Sun G, Zeng H.
PMID: 41954116 [PubMed - indexed for MEDLINE]
Association of EBV infection with increased cancer aggressiveness in prostate cancer patients: A systematic review and meta-analysis.
Adv Clin Exp Med
Abidi SH, Fabiyi OT, Omarova Z, Sheikh A, Ahmed K, Bajpai R.
PMID: 41953983 [PubMed - as supplied by publisher]
Neoadjuvant Toripalimab Plus Axitinib for Nonmetastatic Clear Cell Renal Cell Carcinoma With Tumor Thrombus: A Combined Analysis of Two Phase II Clinical Trials.
MedComm (2020)
Peng C, Wu Z, Wang Y, Liang Q, Wang D, Zhao H, Li J, Yue X, Zhang Y, Song J, Shi C, Wang H, Yang G, Wang B, Huang Q, Zhang X, Ma X, Huang J, Gu L.
PMID: 41953639 [PubMed]
Efficacy and safety of antibody-drug conjugate based therapy in locally advanced or metastatic urothelial carcinoma: a systematic review and network meta-analysis of emerging clinical evidence.
Front Immunol
Dai Y, Xiao C, Wang L, Zhou W, Bo R, Cheng Z, Pan G.
PMID: 41953009 [PubMed - indexed for MEDLINE]
Evaluation and management of transient lower urinary tract symptoms (LUTS) after surgery for Benign prostatic obstruction (BPO): a systematic review.
Prostate Cancer Prostatic Dis
Gallo G, Lombardo R, Cicione A, Cornu JN, Franco A, Fusco F, Malde S, Manfredi C, Netsch C, Rieken M, Gravas S, Gacci M, De Nunzio C.
PMID: 41951848 [PubMed - as supplied by publisher]
Identification of biomarkers for non-invasive diagnosis and risk stratification in prostate cancer using NMR-based metabolomics and machine learning.
NPJ Precis Oncol
Zhang X, Chen M, Xia B, Liu B, Lin X, Tao H, Wang H, Gu T, Li J, Dong B, Gao H.
PMID: 41951831 [PubMed - as supplied by publisher]
Novel Theranostic Targets for Prostate Cancer Beyond Prostate-Specific Membrane Antigen.
PET Clin
Heidari P, Jadvar H, Kako B, Esfahani SA.
PMID: 41951504 [PubMed - as supplied by publisher]
Prostate-Specific Membrane Antigen Theranostics in Prostate Cancer - Current State and Evolving Standards.
PET Clin
Satapathy S, Chandekar KR, Damle NA.
PMID: 41951503 [PubMed - as supplied by publisher]
[Image-Guided Irreversible Electroporation for the Treatment of Localized Prostate Cancer].
Aktuelle Urol
Collettini F, Auer TA, Stephan C, Fischer T, Gebauer B.
PMID: 41950915 [PubMed - indexed for MEDLINE]
Integrative analysis of urinary microRNAs for prostate cancer detection: A proof-of-concept study.
Transl Oncol
Samani LA, Rahmani S, Kashi AH, Ziaee SAM, Mowla SJ.
PMID: 41950670 [PubMed - as supplied by publisher]
Incidental Detection of Glioblastoma Multiforme With PSMA Uptake on Initial Prostate Cancer Staging.
Clin Nucl Med
Ahmadi M, Tanha AS, Elahifard H, Bahonar M, Askari E.
PMID: 41950268 [PubMed - as supplied by publisher]
Assessment of multi-parameter dual-energy CT in predicting muscle invasion in bladder cancer: comparison with VI-RADS.
Insights Imaging
Sun M, Wang J, Luo J, Lai S, Wang L, Liu Y, Wen X, Yu C.
PMID: 41949696 [PubMed]
Association between the psoas muscle index and disease progression and mortality in testicular germ cell tumours.
Indian J Med Res
Özlü DN, Teke K, Danac, Emir B, Avci , Uslubas AK, Arikan Y, Ayten A, Y, Bitkin A.
PMID: 41949134 [PubMed - indexed for MEDLINE]
Clinical application of transurethral resection/electrocautery for urethral hemangiomas: two centers retrospective cohort study.
Scand J Urol
Huang JF, Wu RH, Qi JC, Guo T, He F, Jin YY, Liu L.
PMID: 41948953 [PubMed - indexed for MEDLINE]
Cost-effectiveness of degarelix versus LHRH agonists in prostate cancer: a systematic review.
Front Health Serv
Wang W, Li S, Liu W, You X, Liu Y, Wang X.
PMID: 41948305 [PubMed]
Articles 1 - 20 / 186904
Page 1 of 9346
Rect Bottom
Anzeige
Adserver Footer
Time frame
--unlimited--
1 Week
1 Month
3 Months
6 Months
1 Year
2 Years
3 Years
5 Years
10 Years
Sky right 1
Anzeige
Mediscope AG E-mail:
info@mediscope.ch
Disclaimer
|
Privacy Policy